Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. That said, here is one low-volatility stock that could offer consistent gains and two that may not deliver the returns you need.
Two stocks to sell:
Packaging Corporation of America (PKG)
Rolling one-year beta: 0.06
Founded in 1959, Packaging Corporation of America (NYSE: PKG) produces containerboard and corrugated packaging products as well as displays and package protection.
Why Is PKG Not Exciting?
- Annual revenue growth of 5.8% over the last five years was below our standards for the industrials sector
- Costs have risen faster than its revenue over the last five years, causing its operating margin to decline by 6.3 percentage points
- Diminishing returns on capital suggest its earlier profit pools are drying up
Packaging Corporation of America is trading at $259.04 per share, or 19x forward P/E. To fully understand why you should be careful with PKG, check out our full research report (it’s free).
Fulton Financial (FULT)
Rolling one-year beta: 0.32
Tracing its roots back to 1882 in the heart of Pennsylvania, Fulton Financial (NASDAQ: FULT) is a financial holding company that provides banking, lending, and wealth management services to consumers and businesses across five Mid-Atlantic states.
Why Are We Hesitant About FULT?
- Annual revenue growth of 9.3% over the last two years was below our standards for the banking sector
- Performance over the past five years shows its incremental sales were less profitable, as its 5.1% annual earnings per share growth trailed its revenue gains
- 4.4% annual tangible book value per share growth over the last five years was slower than its banking peers
At $24.11 per share, Fulton Financial trades at 1.2x forward P/B. Read our free research report to see why you should think twice about including FULT in your portfolio.
One stock to watch:
ResMed (RMD)
Rolling one-year beta: 0.21
Founded in 1989 to address the then-underdiagnosed condition of sleep apnea, ResMed (NYSE: RMD) develops cloud-connected medical devices and software solutions that treat sleep apnea, COPD, and other respiratory disorders for home and clinical use.
Why Does RMD Stand Out?
- Steady constant currency growth over the past two years shows the company can pursue its global ambitions, even in uncertain economic times
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 15.7% exceeded its revenue gains over the last five years
- Free cash flow margin increased by 19.1 percentage points over the last five years, giving the company more capital to invest or return to shareholders
ResMed’s stock price of $232.08 implies a valuation ratio of 18.6x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
High-quality stocks for all market conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
